v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series B Preferred Stock
Series C Preferred Stock
Cumulative Redeemable Preferred Stock
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series C Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Redeemable Preferred Stock
Accumulated Deficit
Accumulated Deficit
Series B Preferred Stock
Accumulated Deficit
Series C Preferred Stock
Accumulated Other Comprehensive Income
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2024         8,000,000 11,000,000              
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2024             102,083,000            
Beginning balance at Dec. 31, 2024 $ 1,841,792       $ 80 $ 110 $ 1,021 $ 3,711,046   $ (1,879,941)     $ 9,476
Increase (Decrease) in Stockholders' Equity                          
Net Income/(Loss) 41,176                 41,176      
Issuance of common stock, net of expenses (in shares)             1,081,000            
Issuance of stock, net of expenses (9)     $ 0     $ 11 (20)          
Repurchase of shares of common stock (in shares) [1]             (511,000)            
Repurchase of shares of common stock [1] (5,194)           $ (5) (5,189)          
Equity based compensation expense 5,791             5,791          
Change in accrued dividends attributable to stock-based awards 1,727             1,296   431      
Dividends declared on common stock (36,955)                 (36,955)      
Dividends declared on preferred stock (8,219) $ (3,750) $ (4,469)               $ (3,750) $ (4,469)  
Dividends attributable to dividend equivalents (445)                 (445)      
Change in unrealized gains on securities, net (1,260)                       (1,260)
Preferred stock, shares outstanding, ending balance (in shares) at Mar. 31, 2025         8,000,000 11,000,000              
Common stock, shares outstanding, ending balance (in shares) at Mar. 31, 2025             102,653,000            
Ending balance at Mar. 31, 2025 $ 1,838,404       $ 80 $ 110 $ 1,027 3,712,924   (1,883,953)     8,216
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2025   8,125,000 11,286,000   8,125,000 11,286,000              
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2025 101,663,000           101,663,000            
Beginning balance at Dec. 31, 2025 $ 1,827,695       $ 81 $ 113 $ 1,017 3,718,350   (1,895,541)     3,675
Increase (Decrease) in Stockholders' Equity                          
Net Income/(Loss) (984)                 (984)      
Issuance of preferred stock, net of expenses (in shares)         61,000 100,000              
Issuance of common stock, net of expenses (in shares)         60,439 100,015 858,000            
Issuance of stock, net of expenses (1)     $ 3,427 $ 1 $ 1 $ 8 (9) $ 3,425        
Repurchase of shares of common stock (in shares) [2]             (925,000)            
Repurchase of shares of common stock [2] (9,037)           $ (9) (9,028)          
Equity based compensation expense 6,071             6,071          
Change in accrued dividends attributable to stock-based awards 2,821             225   2,596      
Dividends declared on common stock (36,574)                 (36,574)      
Dividends declared on preferred stock (10,424) $ (3,821) $ (6,603)               $ (3,821) $ (6,603)  
Dividends attributable to dividend equivalents (2,884)                 (2,884)      
Change in unrealized gains on securities, net $ (753)                       (753)
Preferred stock, shares outstanding, ending balance (in shares) at Mar. 31, 2026   8,186,000 11,386,000   8,186,000 11,386,000              
Common stock, shares outstanding, ending balance (in shares) at Mar. 31, 2026 101,596,000           101,596,000            
Ending balance at Mar. 31, 2026 $ 1,779,357       $ 82 $ 114 $ 1,016 $ 3,719,034   $ (1,943,811)     $ 2,922
[1] For the three months ended March 31, 2025 includes approximately $4.9 million (482,079 shares) surrendered for tax purposes related to equity-based compensation awards
[2] For the three months ended March 31, 2026 includes approximately $4.1 million (424,947 shares) surrendered for tax purposes related to equity-based compensation awards